BBIO icon

BridgeBio Pharma
BBIO

Overview Fund Activity

354 hedge funds and large institutions have $8.13B invested in BridgeBio Pharma in 2025 Q2 according to their latest regulatory filings, with 91 funds opening new positions, 135 increasing their positions, 102 reducing their positions, and 33 closing their positions.

Holders
354
Holders Change
+52
Holders Change %
+17.22%
% of All Funds
4.75%
Holding in Top 10
17
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-5.56%
% of All Funds
0.23%
New
91
Increased
135
Reduced
102
Closed
33
Calls
$388M
Puts
$79.7M
Net Calls
+$308M
Net Calls Change
-$83.4M

Top Buyers

1
FCM
1
Farallon Capital Management
California
$341M
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$401M
3
Macquarie Group
3
Macquarie Group
Australia
$90.5M
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$89.9M
5
Norges Bank
5
Norges Bank
Norway
$84.5M

Top Sellers

1
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$573M
2
Viking Global Investors
2
Viking Global Investors
Connecticut
$801M
3
Citadel Advisors
3
Citadel Advisors
Florida
$14.3M
4
DTC
4
Deep Track Capital
Connecticut
$38.9M
5
Assenagon Asset Management
5
Assenagon Asset Management
Luxembourg
$15.1M
Name Market Value Shares Shares
Change 		Shares
Change %
Viking Global Investors
1
Viking Global Investors
Connecticut
$801M 18,555,375 -3,500,000 -16%
Vanguard Group
2
Vanguard Group
Pennsylvania
$712M 16,484,985 +1,584,840 +11%
BlackRock
3
BlackRock
New York
$616M 14,259,479 +901,983 +7%
KKRC
4
Kohlberg Kravis Roberts & Co
New York
$573M 13,260,971 -6,000,000 -31%
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$401M 9,276,532 +2,105,133 +29%
FCM
6
Farallon Capital Management
California
$341M 7,900,000 +2,169,000 +38%
ACM
7
Aisling Capital Management
New York
$262M 6,068,125 – –
State Street
8
State Street
Massachusetts
$255M 5,896,596 +146,977 +3%
Capital Research Global Investors
9
Capital Research Global Investors
California
$172M 3,988,298 -679,104 -15%
FLSM
10
Frazier Life Sciences Management
California
$164M 3,800,457 – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$159M 3,681,580 +178,686 +5%
UBS Group
12
UBS Group
Switzerland
$121M 2,812,499 +613,985 +28%
Invesco
13
Invesco
Georgia
$121M 2,801,065 +594,902 +27%
Goldman Sachs
14
Goldman Sachs
New York
$113M 2,621,251 +397,943 +18%
AllianceBernstein
15
AllianceBernstein
Tennessee
$107M 2,470,558 -213,588 -8%
LCM
16
Laurion Capital Management
New York
$104M 2,411,248 -566,919 -19%
Two Sigma Investments
17
Two Sigma Investments
New York
$101M 2,339,067 +1,495,746 +177%
Macquarie Group
18
Macquarie Group
Australia
$90.5M 2,095,235 +2,003,713 +2,189%
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$89.9M 2,081,253 +1,998,104 +2,403%
Fidelity Investments
20
Fidelity Investments
Massachusetts
$87.5M 2,027,395 -148,404 -7%
Norges Bank
21
Norges Bank
Norway
$84.5M 1,956,654 +1,956,654 New
Manulife (Manufacturers Life Insurance)
22
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$81.7M 1,891,578 +3,815 +0.2%
SUT
23
SC US (TTGP)
California
$80.3M 1,860,364 – –
Pictet Asset Management
24
Pictet Asset Management
Switzerland
$78.5M 1,807,434 -282,834 -14%
WP
25
Woodline Partners
California
$73.6M 1,704,800 +79,045 +5%
1
2 3 4 5